DOXORUBICIN Side Effects

6639792-X | Febrile Neutropenia, Methaemoglobinaemia, Pneumocystis Jiroveci Pneumonia
on Mar 08, 2010 Female patient from IRELAND , 68 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, methaemoglobinaemia, pneumocystis jiroveci pneumonia. Doxorubicin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), PRIMAQUINE (View Primaquine Review and Primaquine Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ).

6627216-8 | Hepatitis B
Patient was taking Doxorubicin (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?) on Mar 04, 2010 from TURKEY Additional patient health information: Male patient , 56 years of age, was diagnosed with non-hodgkin's lymphoma and. Doxorubicin dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6626866-2 | Abdominal Pain, Hiccups, Pneumonia
Adverse event was reported on Feb 26, 2010 by a Male patient taking Doxorubicin (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?) and. Location: GERMANY , 60 years of age, After Doxorubicin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), hiccups, pneumonia (What is pneumonia?). During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6618484-7 | Constipation, Diarrhoea, Fatigue, Herpes Zoster, Hypokalaemia, Hyponatraemia, Hypotension, Infection, Intestinal Obstruction
on Mar 02, 2010 Female patient from POLAND , 57 years of age, was diagnosed with leukaemia plasmacytic and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diarrhoea, fatigue, herpes zoster, hypokalaemia, hyponatraemia, hypotension, infection (What is infection?), intestinal obstruction. Doxorubicin dosage: Days 1-4 Of 21 Day Cycle. During the same period patient was treated with BORTEZOMIB (Days 1, 4, 8, 11 Of 21 Day Cycle) (View Bortezomib Review and Bortezomib Label ), DEXAMETHASONE (Days 1-4 Of 21 Day Cycle) (View Dexamethasone Review and Dexamethasone Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MELPHALAN (View Melphalan Review and Melphalan Label ).


6591340-9 | Hepatitis B
on Feb 15, 2010 Female patient from TURKEY , 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Doxorubicin (View Usage). Patient had the following side effects: hepatitis b (What is hepatitis b?). Doxorubicin dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6591269-6 | Hepatitis B
Patient was taking Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: hepatitis b (What is hepatitis b?) on Feb 15, 2010 from TURKEY Additional patient health information: Male patient , 56 years of age, was diagnosed with non-hodgkin's lymphoma and. Doxorubicin dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6581258-X | Acute Myeloid Leukaemia, Malignant Neoplasm Progression
Adverse event was reported on Feb 08, 2010 by a Female patient taking Doxorubicin (View Usage) (Dosage: ) . Location: ITALY , 34 years of age, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, malignant neoplasm progression. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ).

6526926-0 | Abdominal Distension, Abdominal Pain, Diarrhoea, Febrile Neutropenia, Haematemesis, Jaundice Cholestatic, Pseudomembranous Colitis, Rash Erythematous
on Dec 24, 2009 Female patient from UNITED KINGDOM , 45 years of age, was diagnosed with breast cancer metastatic, prophylaxis, prophylaxis of nausea and vomiting and was treated with Doxorubicin (View Usage). Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), diarrhoea, febrile neutropenia, haematemesis, jaundice cholestatic, pseudomembranous colitis, rash erythematous. Doxorubicin dosage: 50 Mg/m2, Cyclic (2 Cycles). During the same period patient was treated with ERYTHROMYCIN (Unk) (View Erythromycin Review and Erythromycin Label ), DOCETAXEL (75 Mg/m2, Cyclic, 2 Cycles) (View Docetaxel Review and Docetaxel Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GRANISETRON (View Granisetron Review and Granisetron Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6509692-4 | Cardiac Failure
on Dec 21, 2009 Female patient from UNITED STATES , 41 years of age, weighting 177.9 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: cardiac failure. Doxorubicin dosage: 109 Mg Other Iv.

6464579-0 | Febrile Neutropenia, Malaise, Nervousness, Neutrophil Count Decreased
Patient was taking Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, malaise, nervousness, neutrophil count decreased on Nov 19, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, . Doxorubicin dosage: 85 Mg, Unk. During the same period patient was treated with CYCLOPHOSPHAMIDE (850 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), FLUOROURACIL (850 Mg, Unk) (View Fluorouracil Review and Fluorouracil Label ), NEULASTA (6 Mg, Cyclic) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

5987490-8 | Interstitial Lung Disease
Adverse event was reported on Nov 27, 2008 by a Female patient taking Doxorubicin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 56 years of age, weighting 143.3 lb, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with DOCETAXEL (View Docetaxel Review and Docetaxel Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5421485-8 | Anaemia, Bacterial Infection, Confusional State, Disseminated Intravascular Coagulation, Hyperkalaemia, Hyperthermia, Hypotension, Inflammation, Lung Infection
on Aug 06, 2007 Female patient from FRANCE , 42 years of age, was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: anaemia, bacterial infection (What is bacterial infection?), confusional state, disseminated intravascular coagulation, hyperkalaemia, hyperthermia, hypotension, inflammation, lung infection. Doxorubicin dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with VINCRISTINE (Intravenous (not Otherwise Specified)) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (Intravenous (not Otherwise Specified)) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), OXYCODONE HYDROCHLORIDE (View Oxycodone Hydrochloride Review and Oxycodone Hydrochloride Label ). Patient was hospitalized.

5413114-4 | Palmar-plantar Erythrodysaesthesia Syndrome
on Aug 06, 2007 Female patient from AUSTRALIA , 43 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: palmar-plantar erythrodysaesthesia syndrome. Doxorubicin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), ONDASETRON (View Ondasetron Review and Ondasetron Label ), APREPITANT (View Aprepitant Review and Aprepitant Label ). Patient was hospitalized.

5408515-4 | Diverticular Perforation, Gastritis, Mucosal Inflammation, Peptic Ulcer, Sepsis
Patient was taking Doxorubicin (View Usage). Patient had the following side effects: diverticular perforation, gastritis, mucosal inflammation, peptic ulcer (What is peptic ulcer?), sepsis (What is sepsis?) on Aug 06, 2007 from UNITED STATES Additional patient health information: Male patient , 17 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis and. Doxorubicin dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), PEGASPARGASE (View Pegaspargase Review and Pegaspargase Label ). Patient was hospitalized.

5407455-4 | Cardiac Arrest, Ventricular Tachycardia
Adverse event was reported on Aug 06, 2007 by a Female patient taking Doxorubicin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: POLAND , 48 years of age, After Doxorubicin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular tachycardia.

5335345-4 | Acute Pulmonary Oedema, Myocardial Ischaemia, Ventricular Extrasystoles
on May 14, 2007 Male patient from FRANCE , 63 years of age, was diagnosed with neuroendocrine carcinoma and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, myocardial ischaemia, ventricular extrasystoles. Doxorubicin dosage: Daily Dose:37.8mg-freq:daily. During the same period patient was treated with ETOPOSIDE (Daily Dose:90.6mg-freq:daily) (View Etoposide Review and Etoposide Label ), ENDOXAN (Daily Dose:755mg-freq:daily) (View Endoxan Review and Endoxan Label ), CALCIDOSE (View Calcidose Review and Calcidose Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), ARGININE (View Arginine Review and Arginine Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5127068-1 | Jc Virus Infection, Progressive Multifocal Leukoencephalopathy
on Oct 02, 2006 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Doxorubicin (View Usage). Patient had the following side effects: jc virus infection, progressive multifocal leukoencephalopathy. Doxorubicin dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CHLORAMBUCIL (View Chlorambucil Review and Chlorambucil Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ).

5104937-X | Febrile Neutropenia
Patient was taking Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: febrile neutropenia on Sep 08, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 151.5 lb, was diagnosed with breast cancer (What is breast cancer?) and. Doxorubicin dosage: 60mg/ M2 Q2weeks- 4 Cycle Iv. During the same period patient was treated with CYCLOPHOSPHAMIDE (600mg/ M2 Q2weeks- 4 Cycle Iv) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5068948-5 | Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Jul 21, 2006 by a Female patient taking Doxorubicin (View Usage) (Dosage: ) . Location: UNITED STATES , 61 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: palmar-plantar erythrodysaesthesia syndrome.

4889659-2 | Abdominal Pain, Back Pain, Constipation, Device Related Infection, Enterobacter Infection, Febrile Neutropenia
on Jan 20, 2006 Female patient from UNITED STATES , weighting 186.4 lb, was diagnosed with endometrial cancer and was treated with Doxorubicin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), constipation (What is constipation?), device related infection, enterobacter infection, febrile neutropenia. Doxorubicin dosage: See Image. During the same period patient was treated with CISPLATIN (See Image) (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (See Image) (View Paclitaxel Review and Paclitaxel Label ), G CSF (See Image) (View G-csf Review and G-csf Label ), ATIVAN (View Ativan Review and Ativan Label ), EMEND (View Emend Review and Emend Label ), MIRALAX (View Miralax Review and Miralax Label ), SENNA (View Senna Review and Senna Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

4882047-4 | Neutrophil Count Abnormal
on Jan 13, 2006 Female patient from UNITED STATES , weighting 140.2 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: neutrophil count abnormal. Doxorubicin dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ).

4874461-8 | Bacterial Sepsis, Hypotension
Patient was taking Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial sepsis, hypotension on Jan 05, 2006 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, weighting 66.14 lb, was diagnosed with leukaemia, fungal infection (What is fungal infection?) and. Doxorubicin dosage: . During the same period patient was treated with VINCRISTINE (View Vincristine Review and Vincristine Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), NOXAFIL (View Noxafil Review and Noxafil Label ), ASPARAGINASE (1000 Iu/m^2) (View Asparaginase Review and Asparaginase Label ). Patient was hospitalized.

4869132-8 | Eye Swelling, Eyelid Oedema, Impaired Work Ability, Lacrimation Increased, Neuropathy, Vision Blurred
Adverse event was reported on Dec 28, 2005 by a Female patient taking Doxorubicin (View Usage) (Dosage: See Image) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 131.2 lb, Patient had the following side effects: eye swelling, eyelid oedema, impaired work ability, lacrimation increased, neuropathy, vision blurred. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (See Image) (View Docetaxel Review and Docetaxel Label ).

4865092-4 | Acute Endocarditis, Aortic Valve Incompetence, Aortic Valve Stenosis, Cardiac Failure Congestive, Cerebrovascular Accident
on Dec 20, 2005 Female patient from UNITED STATES , weighting 166.5 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: acute endocarditis, aortic valve incompetence, aortic valve stenosis, cardiac failure congestive, cerebrovascular accident. Doxorubicin dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (See Image) (View Docetaxel Review and Docetaxel Label ). Patient was hospitalized.

4865091-2 | Abdominal Pain, Anorectal Disorder, Constipation, Diarrhoea, Gastrointestinal Disorder, Gastrointestinal Necrosis, Gastrointestinal Oedema, Hypotension, Induration
on Dec 20, 2005 Female patient from UNITED STATES , weighting 186.3 lb, was diagnosed with endometrial cancer and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), anorectal disorder, constipation (What is constipation?), diarrhoea, gastrointestinal disorder, gastrointestinal necrosis, gastrointestinal oedema, hypotension, induration. Doxorubicin dosage: See Image. During the same period patient was treated with CISPLATIN (See Image) (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (See Image) (View Paclitaxel Review and Paclitaxel Label ), IMODIUM (View Imodium Review and Imodium Label ), OXYCODONE AND ACETAMINOPHEN (View Oxycodone And Acetaminophen Review and Oxycodone And Acetaminophen Label ). Patient was hospitalized.

4854423-7 | Catheter Related Complication, Thrombosis
Patient was taking Doxorubicin (View Usage). Patient had the following side effects: catheter related complication, thrombosis on Dec 14, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 160.3 lb, was diagnosed with breast cancer (What is breast cancer?) and. Doxorubicin dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (See Image) (View Paclitaxel Review and Paclitaxel Label ), GEMCITABINE (See Image) (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

4839069-9 | Ascites, Cardio-respiratory Arrest, Dyspnoea, Loss Of Consciousness, Pleural Effusion
Adverse event was reported on Nov 28, 2005 by a Male patient taking Doxorubicin (View Usage) (Dosage: See Image) . Location: UNITED STATES , weighting 211.6 lb, After Doxorubicin was administered, patient had the following side effects: ascites, cardio-respiratory arrest, dyspnoea, loss of consciousness, pleural effusion. During the same period patient was treated with GEMCITABINE (See Image) (View Gemcitabine Review and Gemcitabine Label ).

4833746-1 | Catheter Related Infection
on Nov 16, 2005 Female patient from UNITED STATES , weighting 186.4 lb, was diagnosed with endometrial cancer and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter related infection. Doxorubicin dosage: See Image. During the same period patient was treated with CISPLATIN (See Image) (View Cisplatin Review and Cisplatin Label ), TAXOL (See Image) (View Taxol Review and Taxol Label ), G CSF (See Image) (View G-csf Review and G-csf Label ), G CSF (See Image) (View G-csf Review and G-csf Label ), EMEND (View Emend Review and Emend Label ), MIRALAX (View Miralax Review and Miralax Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

4821799-6 | Infection, Osteonecrosis, Tooth Extraction
on Feb 07, 2005 Male patient from UNITED STATES , 58 years of age, was diagnosed with metastases to bone and was treated with Doxorubicin (View Usage). Patient had the following side effects: infection (What is infection?), osteonecrosis (What is osteonecrosis?), tooth extraction. Doxorubicin dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), THIOTEPA (View Thiotepa Review and Thiotepa Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), BUSULPHAN (View Busulphan Review and Busulphan Label ), GENASENSE (View Genasense Review and Genasense Label ), GM CSF (View Gm-csf Review and Gm-csf Label ), ZOLEDRONIC ACID (View Zoledronic Acid Review and Zoledronic Acid Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

4818513-7 | Febrile Neutropenia
Patient was taking Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: febrile neutropenia on Oct 31, 2005 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 190.0 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Doxorubicin dosage: 48 Mg Ivp. During the same period patient was treated with BLEOMYCIN (19 Units Ivp) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE (11.5 Mg Ivp) (View Vinblastine Review and Vinblastine Label ), DACARBAZINE (715 Mg Ivpb) (View Dacarbazine Review and Dacarbazine Label ). Patient was hospitalized.

4814966-9 | Adenoviral Hepatitis, Central Line Infection, Coagulopathy, Congenital Herpes Simplex Infection, Hepatic Encephalopathy, Hepatomegaly, Renal Failure
Adverse event was reported on Oct 19, 2005 by a Male patient taking Doxorubicin (View Usage) (Dosage: ) was diagnosed with acute lymphocytic leukaemia and. Location: UNITED KINGDOM , child 1 years of age, Patient experienced the following unwanted or unexpected effects: adenoviral hepatitis, central line infection, coagulopathy, congenital herpes simplex infection, hepatic encephalopathy, hepatomegaly, renal failure. During the same period patient was treated with ASPARAGINASE (1000 (unit)/m2) (View Asparaginase Review and Asparaginase Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

4809810-X | Cardiac Failure, Cardiomyopathy, Ejection Fraction Decreased, Lymphadenopathy
on Oct 24, 2005 Male patient from ZAMBIA , weighting 239.2 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Doxorubicin (View Usage). Patient had the following side effects: cardiac failure, cardiomyopathy (What is cardiomyopathy?), ejection fraction decreased, lymphadenopathy. Doxorubicin dosage: See Image. During the same period patient was treated with VINBLASTINE (See Image) (View Vinblastine Review and Vinblastine Label ), VINCRISTINE (See Image) (View Vincristine Review and Vincristine Label ), BLEOMYCIN (See Image) (View Bleomycin Review and Bleomycin Label ), CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

4808924-8 | Catheter Site Cellulitis
on Oct 20, 2005 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: catheter site cellulitis. Doxorubicin dosage: See Image. During the same period patient was treated with VINBLASTINE (See Image) (View Vinblastine Review and Vinblastine Label ), GEMCITABINE (See Image) (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

4801516-6 | Ascites, Cardio-respiratory Arrest, Dyspnoea, Loss Of Consciousness, Pleural Effusion
Patient was taking Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, cardio-respiratory arrest, dyspnoea, loss of consciousness, pleural effusion on Oct 13, 2005 from UNITED STATES Additional patient health information: Male patient , weighting 211.6 lb, . Doxorubicin dosage: See Image. During the same period patient was treated with GEMCITABINE (See Image) (View Gemcitabine Review and Gemcitabine Label ).

4761478-7 | Erythema, Neutrophil Count Abnormal, Oedema Peripheral, Pain, Thrombosis
Adverse event was reported on Sep 02, 2005 by a Male patient taking Doxorubicin (View Usage) (Dosage: See Image) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , weighting 270.3 lb, Patient had the following side effects: erythema, neutrophil count abnormal, oedema peripheral, pain (What is pain?), thrombosis. During the same period patient was treated with BLEOMYCIN (See Image) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE (See Image) (View Vinblastine Review and Vinblastine Label ), DACARBAZINE (See Image) (View Dacarbazine Review and Dacarbazine Label ).

4761107-2 | Deep Vein Thrombosis, Pulmonary Embolism
on Sep 01, 2005 Female patient from UNITED STATES , weighting 135.8 lb, was diagnosed with ureteric cancer and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). Doxorubicin dosage: See Image. During the same period patient was treated with GEMCITABINE (See Image) (View Gemcitabine Review and Gemcitabine Label ), PACLITAXEL (See Image) (View Paclitaxel Review and Paclitaxel Label ), CISPLATIN (See Image) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

4761106-0 | Ejection Fraction Decreased, Myocardial Infarction, Myocardial Ischaemia, Scar, Ventricular Dysfunction
on Sep 01, 2005 Male patient from UNITED STATES , weighting 270.3 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: ejection fraction decreased, myocardial infarction, myocardial ischaemia, scar (What is scar?), ventricular dysfunction. Doxorubicin dosage: See Image. During the same period patient was treated with BLEOMYCIN (See Image) (View Bleomycin Review and Bleomycin Label ), VINBLASTINE (See Image) (View Vinblastine Review and Vinblastine Label ), DACARBAZINE (See Image) (View Dacarbazine Review and Dacarbazine Label ).

4761104-7 | Asthenia, Dehydration, Haemoglobin Abnormal, Hypokalaemia, Hypoxia, Infection, Metastases To Lung, Nausea, Neutropenia
Patient was taking Doxorubicin (View Usage). Patient had the following side effects: asthenia, dehydration, haemoglobin abnormal, hypokalaemia, hypoxia, infection (What is infection?), metastases to lung, nausea (What is nausea?), neutropenia on Sep 01, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 145.3 lb, was diagnosed with endometrial cancer and. Doxorubicin dosage: See Image. During the same period patient was treated with CISPLATIN (See Image) (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (See Image) (View Paclitaxel Review and Paclitaxel Label ), NEULASTA (See Image) (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

4750375-9 | Cardiomyopathy, Dyspnoea, Infection, Pancytopenia, Pulmonary Function Test Decreased, Respiratory Failure
Adverse event was reported on Aug 19, 2005 by a Male patient taking Doxorubicin (View Usage) (Dosage: See Image) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , weighting 242.5 lb, After Doxorubicin was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), dyspnoea, infection (What is infection?), pancytopenia, pulmonary function test decreased, respiratory failure. During the same period patient was treated with VINBLASTINE (See Image) (View Vinblastine Review and Vinblastine Label ), VINCRISTINE (See Image) (View Vincristine Review and Vincristine Label ), BLEOMYCIN (See Image) (View Bleomycin Review and Bleomycin Label ), CYCLOPHOSPHAMIDE (See Image) (View Cyclophosphamide Review and Cyclophosphamide Label ), VP 16 (See Image) (View Vp-16 Review and Vp-16 Label ), PREDNISONE TAB (See Image) (View Prednisone Tab Review and Prednisone Tab Label ).

4726245-9 | Hypotension, Sepsis, Staphylococcal Infection, Subcutaneous Abscess, Wound Infection
on Jul 25, 2005 Female patient from UNITED STATES , weighting 220.5 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, sepsis (What is sepsis?), staphylococcal infection (What is staphylococcal infection?), subcutaneous abscess, wound infection. Doxorubicin dosage: See Image. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

4724498-4 | Scleroderma
on Jun 30, 2005 Female patient from UNITED STATES , 39 years of age, was diagnosed with breast cancer metastatic and was treated with Doxorubicin (View Usage). Patient had the following side effects: scleroderma (What is scleroderma?). Doxorubicin dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), LEUCOVORIN (View Leucovorin Review and Leucovorin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ).

4712850-2 | Fatigue, Febrile Neutropenia, Nausea, Septic Shock, Stomatitis
Patient was taking Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: fatigue, febrile neutropenia, nausea (What is nausea?), septic shock, stomatitis on Jul 12, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 147.7 lb, was diagnosed with breast cancer (What is breast cancer?) and. Doxorubicin dosage: 60 Mg/m2. During the same period patient was treated with CYCLOPHOSPHAMIDE (600 Mg/m2 Iv Q 3 Wks X 4 Cycles) (View Cyclophosphamide Review and Cyclophosphamide Label ).

4709208-9 | Skin Reaction
Adverse event was reported on Jul 07, 2005 by a Female patient taking Doxorubicin (View Usage) (Dosage: 25 Mg/m2 Iv Push) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , weighting 231.5 lb, Patient experienced the following unwanted or unexpected effects: skin reaction. During the same period patient was treated with VINBLASTINE (6 Mg/m2 Iv Push) (View Vinblastine Review and Vinblastine Label ), GEMCITABINE (800 Mg/m2 Iv Bolus) (View Gemcitabine Review and Gemcitabine Label ), ATIVAN (View Ativan Review and Ativan Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

4704990-9 | Acute Pulmonary Oedema, Cardiac Enzymes Increased, Lactic Acidosis, Left Ventricular Failure, Renal Failure, Ventricular Dysfunction
on Jun 20, 2005 Female patient from UNITED STATES , 78 years of age, was diagnosed with carcinoid tumour of the small bowel and was treated with Doxorubicin (View Usage). Patient had the following side effects: acute pulmonary oedema, cardiac enzymes increased, lactic acidosis, left ventricular failure, renal failure, ventricular dysfunction. Doxorubicin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), MITOMYCIN (View Mitomycin Review and Mitomycin Label ). Patient was hospitalized.

4704102-1 | Acute Promyelocytic Leukaemia
on Jun 14, 2005 Male patient from , 51 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: acute promyelocytic leukaemia. Doxorubicin dosage: 300 Mg/m2 Total. During the same period patient was treated with BLEOMYCIN (40 Mg/m2 Total) (View Bleomycin Review and Bleomycin Label ), METHOTREXATE (6000 Mg/m2 Total) (View Methotrexate Review and Methotrexate Label ), CYTARABINE (800 Mg/m2 Total) (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (1200 Mg/m2 Total) (View Etoposide Review and Etoposide Label ), CYCLOPHOSPHAMIDE (4800 Mg/m2 Total) (View Cyclophosphamide Review and Cyclophosphamide Label ), VINDESINE (8 Mg/m2 Total) (View Vindesine Review and Vindesine Label ), IFOSFAMIDE (6000 Mg/m2 Total) (View Ifosfamide Review and Ifosfamide Label ).

4697718-2 | Local Swelling, Neutropenia, Onychomycosis, Pain In Extremity, Wound Drainage
Patient was taking Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: local swelling, neutropenia, onychomycosis, pain in extremity, wound drainage on Jun 21, 2005 from Additional patient health information: Female patient , 66 years of age, weighting 208.3 lb, was diagnosed with adenocarcinoma, metastasis and. Doxorubicin dosage: 123 Mg Ivp. During the same period patient was treated with CYCLOPHOSPHAMIDE (1233 Mg Ivpb) (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

4694160-5 | Activated Partial Thromboplastin Time Prolonged, Bacteria Urine, Blood Calcium Decreased, Blood Culture Positive, Blood Potassium Decreased, Blood Pressure Decreased, Blood Pressure Systolic Increased, Blood Sodium Decreased, Blood Urine
Adverse event was reported on Jun 17, 2005 by a Female patient taking Doxorubicin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: , weighting 142.3 lb, Patient had the following side effects: activated partial thromboplastin time prolonged, bacteria urine, blood calcium decreased, blood culture positive, blood potassium decreased, blood pressure decreased, blood pressure systolic increased, blood sodium decreased, blood urine. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ).

4690472-X | Atrial Fibrillation, Cardiac Failure Congestive, Cardiomyopathy, Chest Pain, Ventricular Hypokinesia
on Jun 14, 2005 Female patient from , 57 years of age, was diagnosed with ovarian cancer, recurrent cancer and was treated with Doxorubicin (View Usage). After Doxorubicin was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), ventricular hypokinesia. Doxorubicin dosage: . During the same period patient was treated with TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ). Patient was hospitalized.

4688751-5 | Cardiomyopathy
on Jun 09, 2005 Female patient from , 43 years of age, weighting 125.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doxorubicin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomyopathy (What is cardiomyopathy?). Doxorubicin dosage: . During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ), ADVAIR (View Advair Review and Advair Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

4688674-1 | Anaemia, Diarrhoea, Hypokalaemia, Hypovolaemia, Pyrexia, White Blood Cells Stool Positive
Patient was taking Doxorubicin (View Usage). Patient had the following side effects: anaemia, diarrhoea, hypokalaemia, hypovolaemia, pyrexia, white blood cells stool positive on Jun 10, 2005 from Additional patient health information: Female patient , weighting 222.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Doxorubicin dosage: (60 Mg/m2). During the same period patient was treated with CYCLOPHOSPHAMIDE ((600 Mg/m2) Every 2 Weeks For 4 Cycles, Followed By Paclitaxel) (View Cyclophosphamide Review and Cyclophosphamide Label ), PACLITAXEL ((175 Mg/m2) Every 2 Weeks For 4 Cycles) (View Paclitaxel Review and Paclitaxel Label ).